Our Team | Integrated BioTherapeutics

M. Javad Aman, PhD

PRESIDENT AND CSO

Javad leads IBT and its innovative science programs. He is a distinguished researcher in viral and bacterial diseases with 75+ publications.

Gary Nabors, PhD

EVP, Chief Development Officer

Gary heads IBT’s product development team to translate its discovery pipeline into practical solutions for infectious diseases. See Gary’s publication.

Rick Holtsberg, PhD

VP, Manufacturing & Bioanalytics

Rick leads IBT Bioservices’ assay & protein services group and develops IBT’s biochemical reagent portfolio. See Rick’s publications.

Robin Douglas

VP, Programs & Operations

Robin leads IBT Bioservices with its state-of-the-art infectious disease research capabilities and strong customer service focus.

Rajan Adhikari, PhD

Associate Director, Bacterial Therapeutics

Rajan investigates bacterial pathogens and leads antibacterial vaccine and therapeutic development programs. See Rajan’s publications.

Hatice Karauzum, PhD

Associate Director, Translational Research

Hati investigates bacterial pathogenesis and cellular immune responses. See Hati’s publications.

Agnes Chenine, PhD

Assistant Director, Antiviral Research

Agnes oversees the in vivo studies program for testing new therapies and vaccines in various rodent models. See Agnes’s publications.

Sergey Shulenin, PhD

Assistant Director, Protein Chemistry

Sergey works on assay development and protein expression. See Seregy’s publications.

Thomas Kort

Principal Scientist

Tom works on protein expression and custom scientific projects. See Tom’s publications.

Haimi Shiferaw

Business Development Advisor

Haimi leads IBT Bioservices strategic growth, marketing, and customer management team.

Our Partners